We work passionately to develop, manufacture, and supply active ingredient solutions for our healthcare partners around the world. We leverage our industrial expertise and experience to deliver solutions that meet the highest quality, social and environmental requirements — all while ensuring stakeholder' satisfaction.With approximately €1 billion in expected sales by 2022, EUROAPI will rank #1 in small molecule APIs, and our strong innovation and R&D capabilities allow us to accelerate our development in more complex molecules’ segments through CDMO.Counting approximately 200 APIs, EUROAPI offers one of the largest portfolios in the industry, addressing a wide pop...